References
- Shi Y, Huang Y, Zhang TT, et al. Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition). J Thorac Dis. 2019;11:2581–2616.
- Kunst G, Milojevic M, Boer C, et al. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth. 2019;123:713–757.
- Monaco F, Di Prima AL, De Luca M, et al. Periprocedural and perioperatory management of patients with tricuspid valve disease. Minerva Cardioangiol. 2018;66(6):691–699.
- Auffret V, Puri R, Urena M, et al. Conduction disturbances after transcatheter aortic valve replacement: current status and future perspectives. Circulation. 2017;136:1049–1069.
- Johnson DW, Erwin JP. III use of impella 5.0 prior to transcatheter aortic valve replacement in a patient with severe aortic stenosis and cardiogenic shock. J Heart Valve Dis. 2017;26:485–487.
- American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.
- Krasopoulos G, Falconieri F, Benedetto U, et al. European real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registries. J Cardiothorac Surg. 2016;11:159.
- Barbanti M, Gulino S, Costa G, et al. Pathophysiology, incidence and predictors of conduction disturbances during transcatheter aortic valve implantation. Expert Rev Med Devices. 2017;14:135–147.8.
- Aloisio E, Dolci A, Panteghini M. Procalcitonin: between evidence and critical issues. Clin Chim Acta. 2019;496:7–12.
- Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2012;165:867–903.
- Mitchell BG, Russo PL, Cheng AC, et al. Strategies to reduce non-ventilator-associated hospital-acquired pneumonia: a systematic review. Infect Dis Health. 2019;24:229–239.
- Memet O, Zhang L, Shen J. Serological biomarkers for acute mesenteric ischemia. Ann Transl Med. 2019;7:394.
- Jiao J, Wang M, Zhang J, et al. Procalcitonin as a diagnostic marker of ventilator-associated pneumonia in cardiac surgery patients. Exp Ther Med. 2015;9:1051–1057.
- Kargaltseva NM, Kotcherovets VI, Mironov AY, et al. Inflammation markers and bloodstream infection (review of literature). Klin Lab Diagn. 2019;64:435–442.
- Wolf TA, Wimalawansa SJ, Razzaque MS. Procalcitonin as a biomarker for critically ill patients with sepsis: Effects of vitamin D supplementation. J Steroid Biochem Mol Biol. 2019;193:105428.
- Cui W, Liu H, Ni H, et al. Diagnostic accuracy of procalcitonin for overall and complicated acute appendicitis in children: a meta-analysis. Ital J Pediatr. 2019;45:78.
- Arif T, Phillips RS. Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer. Pediatr Blood Cancer. 2019;66:e27887.
- Jun J, Lee SR, Lee JY, et al. Pneumonitis and concomitant bacterial pneumonia in patients receiving pembrolizumab treatment: Three case reports and literature review. Medicine (Baltimore). 2019;98:e16158.